Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Recommendation of "Buy" from Brokerages
المصدر:
Buzz FX
/
18 مارس 2025 01:51:16 America/Los_Angeles
N/A
شارك على،